Spotlight
A selection of resources from across the Federation
HIV Theory of Change
Our HIV Theory of Change is to clarify the goals and vision of IPPF’s HIV programme and to articulate the different pathways and strategies IPPF uses to contribute towards its HIV goals and vision.
Filter our resources by:
| 17 January 2020
Tanzania: Fighting back against the Global Gag Rule
In 2017, the US administration implemented the Global Gag Rule (GGR), a policy that denied funding to organizations that provided abortion care. IPPF refused to sign the policy that required us to deny women and girls the freedom to choose what happens to their body. As a result, IPPF lost $100 million in funding. Our Member Association in Tanzania – Chama cha Uzazi na Malezi Bora Tanzania (UMATI) – was forced to close 5 of its 11 clinics. But thanks to emergency funding from the Belgium government, UMATI was able to improve their remaining clinics, increase the number of qualified staff and continue to provide quality care for those who need it. Find out more about the Global Gag Rule and its devastating impact
| 06 December 2019
IMAP statement on expanding access and contraceptive choice through integrated sexual and reproductive health services
In 2018, IPPF endorsed the WHO/UNFPA Call to Action to Attain Universal Health Coverage Through Linked Sexual and Reproductive Health and Rights and HIV Interventions.13 This IMAP statement serves as a reminder of this call to action to ensure all people have access to comprehensive SRH services, including integrated contraceptive and HIV/STI services, provided through primary healthcare.
| 28 October 2019
After the ECHO trial – Expanding access and choice through integrated services
Since the early 1990s, the evidence has been inconclusive as to whether using hormonal contraception increases women’s risk of acquiring HIV, particularly among progestogen-only injectable users. Observational studies indicated that women using progestogen-only injectable contraceptive methods may be at higher risk of acquiring human immunodeficiency virus (HIV). The Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial finds no link between HIV acquisition and the use of DMPA-IM, progestogen implant, and non-hormonal copper IUD. For more information please see the technical brief on the ECHO trial. Following the release of the result of the ECHO trial and the WHO latest guidance statement and revised Medical Eligibility Criteria (MEC) for contraceptive use, IPPF developed a follow-up technical brief to support IPPF MAs and frontline service providers’ work regarding the provision of the integrated contraceptive, HIV and other STI programmes to expand access and contraceptive choice. For more information, please see the attached technical brief After the ECHO trial – Expanding access and choice through integrated services, available in English and French.
| 09 July 2019
IPPF Technical Brief on the ECHO trial
Since the early 1990s, the evidence has been inconclusive as to whether using hormonal contraception increases women’s risk of acquiring HIV, particularly among progestogen-only injectable users. Observational studies indicated that women using progestogen-only injectable contraceptive methods may be at higher risk of acquiring human immunodeficiency virus (HIV). The ECHO trial finds no link between HIV acquisition and the use of DMPA-IM, progestogen implant, and non-hormonal copper IUD.
| 03 April 2019
Improving the quality and availability of post-abortion care in a humanitarian crisis
The world is facing stronger and longer natural disasters, protracted complex emergencies, conflicts and epidemics. These humanitarian crises can expose weakness in health systems, with particularly serious consequences for women and girls in need of reproductive health care. To improve the quality and availability of post‑abortion care during a flood, the University of Leicester and International Planned Parenthood Federation South Asia Region (IPPF-SAR), in collaboration with the Government of Bangladesh, developed and measured the impact of an integrated intervention package, called RHCC. First tested in a flood-prone area of Bangladesh, this novel approach includes: i) Pre-positioning medicines and supplies, using the UNFPA’s Inter-Agency Reproductive Health Kit 8; ii) Capacity building of service providers; and iii) Community awareness raising. Supported by IPPF's Innovation Programme, the project aligns with IPPF’s commitment to ensuring that crisis-affected populations receive timely, quality, life-saving, gender-responsive and inclusive sexual and reproductive health services.
| 28 September 2018
Watch: Access & Abortion: Medical abortion in Nepal
After years of progressive change by activists, advocates and organizations, abortion in Nepal was finally legalized in 2002. Legalization, however, did not mean accessibility, especially to women and girls in hard-to-reach and rural areas. That is until medical abortion became an option. Since being introduced in 2009, medical abortion (the abortion pill), is revolutionizing how women access abortion care with almost half of the abortions performed in Nepal are through the medical procedure. Through clinics, outreach programmes, workshops and peer educators, our Member Association, Family Planning Association of Nepal are ensuring women and girls in hard-to-reach and rural areas know their abortion care options.